Trial NCT00748189

View at ClinicalTrials.gov 
Org. Study IDs: OMB110911
Secondary IDs: OMB110911

Last trial update was posted on 2019-06-25

MeSH Interventions

Chlorambucil Ofatumumab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

Leukaemia, Lymphocytic, Chronic

Stopping Reasons

Majority of patients (62%) had been treated with next line therapies, including new highly effective therapies confounding the interpretation of the OS results.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID